MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comorbid Moyamoya Disease and Parkinson’s disease: A case series

D. Yoo (Seoul, Republic of Korea)

Meeting: MDS Virtual Congress 2021

Abstract Number: 888

Keywords: Parkinson’s, Positron emission tomography(PET)

Category: Parkinson's Disease: Neuroimaging

Objective: We report the first case series of comorbid Moyamoya disease (MMD) and Parkinson’s disease (PD).

Background: MMD is characterized by angiographic findings of bilateral stenosis or occlusion at the terminal end of internal carotid arteries along with abnormal collateral vascular network around narrowing arteries. Vascular parkinsonism has been reported as atypical presentations of MMD, but idiopathic PD has never been discussed with comorbid presumably genetic form of MMD.

Method: Case series

Results: We present two patients with prolonged history of MMD who developed parkinsonian symptoms after several years and one patient who diagnosed both with PD and asymptomatic MMD at the same time. Two patients previously diagnosed with MMD by transient ischemia attack without neurological sequalae or incidentally found at the regular check-up. No clinically significant structural lesions were found on the brain MRI of all cases. Dopamine transporter (DAT) imaging with 18F-FP-CIT PET showed severely decreased DAT densities with asymmetry and anteroposterior gradient, suggesting of synaptic terminal loss of nigrostriatal dopaminergic neurons in PD. Clinical manifestations of laterality were consistent with severity of decreased DAT uptakes and levodopa was effective in all patients.

Conclusion: MMD and PD do coexist although it is rare and the first report to our knowledge. The relevant pathophysiology needs to be elucidated through future post-mortem neuropathological studies.

To cite this abstract in AMA style:

D. Yoo. Comorbid Moyamoya Disease and Parkinson’s disease: A case series [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/comorbid-moyamoya-disease-and-parkinsons-disease-a-case-series/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/comorbid-moyamoya-disease-and-parkinsons-disease-a-case-series/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley